An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers

[1]  A. Boonstra,et al.  Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells , 2018, Journal of Virology.

[2]  Zhenlong Liu,et al.  Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation , 2018, Scientific Reports.

[3]  P. Moore,et al.  Case report: mechanisms of HIV elite control in two African women , 2018, BMC Infectious Diseases.

[4]  L. Su,et al.  Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection. , 2017, JCI insight.

[5]  R. Sutton,et al.  Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers , 2017, The Yale journal of biology and medicine.

[6]  N. Paul,et al.  HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection , 2017, EBioMedicine.

[7]  M. Ge,et al.  Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex , 2017, Viruses.

[8]  Bin Zhou,et al.  Mx Is Not Responsible for the Antiviral Activity of Interferon-α against Japanese Encephalitis Virus , 2017, Viruses.

[9]  Hui Zhang,et al.  GADD45 proteins inhibit HIV-1 replication through specific suppression of HIV-1 transcription. , 2016, Virology.

[10]  P. Goulder,et al.  Subdominant Gag-specific anti-HIV efficacy in an HLA-B∗57-positive elite controller , 2016, AIDS.

[11]  M. Malim,et al.  HIV-1 and interferons: who's interfering with whom? , 2015, Nature Reviews Microbiology.

[12]  S. Bosinger,et al.  Type I Interferon: Understanding Its Role in HIV Pathogenesis and Therapy , 2015, Current HIV/AIDS Reports.

[13]  F. Pereyra,et al.  A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers. , 2014, Cell host & microbe.

[14]  A. Iwamoto,et al.  Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection , 2000, Archives of Virology.

[15]  B. Walker,et al.  Unravelling the mechanisms of durable control of HIV-1 , 2013, Nature Reviews Immunology.

[16]  L. Lopalco,et al.  A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients , 2013, PloS one.

[17]  N. Imami,et al.  Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses , 2013, Front. Immunol..

[18]  N. Saksena,et al.  Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. , 2013, Virology.

[19]  Yan Lin,et al.  An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection , 2012, Bioinform..

[20]  M. Weitzman,et al.  Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11 , 2012, Nature.

[21]  B. Autran,et al.  Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection. , 2012, The Journal of infectious diseases.

[22]  A. Telenti,et al.  Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller , 2012, PloS one.

[23]  R. Koup,et al.  Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers , 2012, Journal of Virology.

[24]  F. Pereyra,et al.  High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control , 2011, Journal of Virology.

[25]  P. D. de Bakker,et al.  Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. , 2011, The Journal of clinical investigation.

[26]  B. Rodés,et al.  Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. , 2011, Clinical immunology.

[27]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[28]  Kristen K. Dang,et al.  Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals , 2010, PLoS pathogens.

[29]  D. Shields,et al.  Meta-Analysis To Test the Association of HIV-1 nef Amino Acid Differences and Deletions with Disease Progression , 2010, Journal of Virology.

[30]  Alan S. Perelson,et al.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.

[31]  D. Costagliola,et al.  Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV , 2009, AIDS.

[32]  D. H. Young,et al.  Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. , 2009, Blood.

[33]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[34]  R. Siliciano,et al.  Elite suppression of HIV-1 replication. , 2008, Immunity.

[35]  Douglas G Altman,et al.  Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets , 2008, PLoS medicine.

[36]  N. Saksena,et al.  Impaired nuclear import and viral incorporation of Vpr derived from a HIV long-term non-progressor , 2008, Retrovirology.

[37]  B. Rodés,et al.  Elite HIV controllers: myth or reality? , 2007, AIDS reviews.

[38]  David A. Price,et al.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.

[39]  F. Mulcahy,et al.  Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. , 2007, Clinical immunology.

[40]  Amalio Telenti,et al.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.

[41]  R. Siliciano,et al.  Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors , 2006, Journal of Virology.

[42]  M. McElrath,et al.  Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection1 , 2006, The Journal of Immunology.

[43]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[44]  Jeffrey N. Martin,et al.  Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment , 2005, Journal of Virology.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[47]  Michael D. George,et al.  Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Badley,et al.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.

[49]  D. Cooper,et al.  Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection. , 2002, Virology.

[50]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[51]  M. Mulligan,et al.  Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.

[52]  J. Levy,et al.  Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease. , 1999, AIDS research and human retroviruses.

[53]  F. Veglia,et al.  Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. , 1999, Virology.

[54]  B. Autran,et al.  Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. , 1999, Blood.

[55]  A. di Caro,et al.  Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor , 1998, Journal of Virology.

[56]  H. Sheppard,et al.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression , 1995, Journal of virology.

[57]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .

[58]  J L Sullivan,et al.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. , 1995, The New England journal of medicine.